Access cutting-edge pancreas adenocarcinoma treatment through this clinical trial at a research site in Charlotte. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Charlotte location
Preparing your pre-screening questions…
Access pancreas adenocarcinoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreas adenocarcinoma treatment provided free
Check if you qualify for this pancreas adenocarcinoma clinical trial in Charlotte, NC
No-Cost Study Care
Local to Charlotte
Convenient for NC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
A major complication of pancreatic adenocarcinoma (PDAC) is cancer cachexia (CC) which is a complex syndrome characterized by skeletal muscle mass loss (with or without loss of fat mass) and progressive functional impairment not reversible by conventional nutritional support. It is estimated to occur in over 75% of patients with advanced PDAC, the highest incidence of all solid tumors, and contributes significantly to poor outcomes and mortality. Though there is overlap amongst the pathophysiologic studies evaluating CC in murine models of different tumor types, the high prevalence of CC within gastrointestinal (GI) malignancies and specifically PDAC suggest that dedicated studies evaluating polymorphisms in candidate genes specific to PDAC warrant further evaluation. The collection and analysis of specimens under this study will facilitate the identification and characterization of genomic polymorphisms associated with CC in PDAC patients. Subsequently, this data may help contribute towards diagnostic and therapeutic treatments that may improve patient outcomes.
Sponsor: Wake Forest University Health Sciences
Yes, this clinical trial (NCT05376592) has an active research site in Charlotte, NC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for pancreas adenocarcinoma treatment options in Charlotte, NC, this clinical trial (NCT05376592) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Charlotte research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreas adenocarcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all pancreas adenocarcinoma clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in Charlotte — not just this study.
Browse Alzheimers Disease Trials in Charlotte →